{"id":787,"date":"2026-11-16T15:52:18","date_gmt":"2026-11-16T15:52:18","guid":{"rendered":"https:\/\/depcell.com\/?page_id=787"},"modified":"2026-11-16T15:52:19","modified_gmt":"2026-11-16T15:52:19","slug":"clinical-trial-proposals-26-ta-2066","status":"publish","type":"page","link":"https:\/\/depcell.com\/lv\/insights\/clinical-trial-proposals-26-ta-2066\/","title":{"rendered":"Clinical trial proposals \u2014 joint contribution"},"content":{"rendered":"<style>\n.wp-block-post-title,.wp-block-columns:has(.wp-block-post-title){display:none!important}\n.dp-policy{max-width:1200px!important;margin:0 auto;padding:32px clamp(18px,4vw,52px) 60px;background:#eeeae6;color:#142534;font-family:inherit;line-height:1.65;box-sizing:border-box}\n.dp-policy *{box-sizing:border-box}.dp-policy h1{font-size:clamp(36px,5vw,68px);line-height:1.08;letter-spacing:-.035em;margin:22px 0 28px;color:#142534}.dp-policy h2{font-size:clamp(25px,3vw,36px);line-height:1.2;margin:20px 0;color:#142534}.dp-policy h3{font-size:23px;line-height:1.3;color:#142534}.dp-policy p,.dp-policy li,.dp-policy td,.dp-policy summary{color:#142534!important}.dp-policy p{font-size:18px;max-width:85ch}.dp-policy .dp-lead{font-size:clamp(21px,2.1vw,28px);line-height:1.5}.dp-policy .dp-eyebrow{text-transform:uppercase;font-size:13px;font-weight:750;letter-spacing:.12em}.dp-policy header{padding:36px 0;border-top:3px dashed #233b51}.dp-policy section{padding:32px 0;border-top:1px solid #a8b0b6}.dp-policy .dp-timeline{display:grid;grid-template-columns:repeat(3,minmax(0,1fr));gap:18px;margin:25px 0}.dp-policy .dp-card{padding:22px;border:1px solid #aeb7be;border-top:4px solid #248e8f;background:rgba(255,255,255,.28)}.dp-policy .dp-card p{font-size:17px}.dp-policy .dp-card h3{margin:10px 0}.dp-policy .dp-num{font-size:30px;font-weight:700;color:#146c70}.dp-policy .dp-status{border-left:4px solid #248e8f;padding:12px 22px;background:rgba(255,255,255,.4);margin:24px 0}.dp-policy a{color:#174c70!important;text-underline-offset:3px;overflow-wrap:anywhere}.dp-policy .dp-button{display:inline-block;background:#223b51;color:#fff!important;text-decoration:none;padding:12px 20px;margin:8px 12px 8px 0}.dp-policy details{border-top:1px solid #acb5bc;padding:18px 0}.dp-policy summary{font-size:21px;font-weight:650;cursor:pointer;line-height:1.4}.dp-policy details[open]>summary{margin-bottom:22px}.dp-policy .source-doc p,.dp-policy .source-doc h2,.dp-policy .source-doc h3,.dp-policy .source-doc h4{white-space:pre-line}.dp-policy .source-doc{padding:0 8px}.dp-policy .source-doc h4{font-size:20px;margin:25px 0 10px}.dp-policy .source-doc h2{font-size:30px}.dp-policy .source-doc h3{font-size:25px}.dp-policy .source-doc p{font-size:17px}.dp-policy .dp-meta{font-size:15px}.dp-policy .dp-table{width:100%;border-collapse:collapse;font-size:16px}.dp-policy .dp-table th{background:#223b51;color:white;text-align:left}.dp-policy .dp-table th,.dp-policy .dp-table td{border:1px solid #bec6cc;padding:12px;vertical-align:top}.dp-policy .dp-scroll{overflow-x:auto}.dp-policy .dp-hero{margin:12px 0 30px}.dp-policy .dp-hero img{display:block;width:100%;height:auto;border-radius:6px}.dp-policy figcaption{font-size:14px;margin:8px 0}.dp-policy .dp-submission{white-space:pre-line;overflow-wrap:anywhere;font-size:17px}.dp-policy nav{display:flex;flex-wrap:wrap;gap:14px;margin:24px 0}\n@media(max-width:640px){.dp-policy{padding:22px 16px 40px}.dp-policy .dp-timeline{grid-template-columns:1fr}.dp-policy .dp-card{padding:18px}.dp-policy section{padding:24px 0}.dp-policy .dp-table{font-size:14px}.dp-policy .dp-table th,.dp-policy .dp-table td{padding:8px}.dp-policy header{padding:26px 0}.dp-policy .dp-submission{font-size:16px}}\n<\/style>\n<br \/>\n<\/p>\n<article class=\"dp-policy\" lang=\"lv\">\n<header>\n<p class=\"dp-eyebrow\">Insights \u00b7 26-TA-2066 \u00b7 16.11.2026<\/p>\n<h1>Kop\u012bgs ieguld\u012bjums kl\u012bnisko p\u0113t\u012bjumu regul\u0113jum\u0101<\/h1>\n<p class=\"dp-lead\">DEPCELL un SIA \u201cCilmes \u0161\u016bnu tehnolo\u0123ijas\u201d sadarb\u012bbas rezult\u0101ts \u2014 uz\u0146\u0113muma atzinums un Ulda B\u0113rzi\u0146a TAP port\u0101l\u0101 iesniegtie priek\u0161likumi dro\u0161am, sam\u0113r\u012bgam ATMP kl\u012bnisko p\u0113t\u012bjumu regul\u0113jumam.<\/p>\n<\/header>\n<figure class=\"dp-hero\"><img decoding=\"async\" src=\"https:\/\/depcell.com\/wp-content\/uploads\/2026\/11\/DEPCELL_TAP_26-TA-2066.png\" alt=\"DEPCELL un SIA Cilmes \u0161\u016bnu tehnolo\u0123ijas sadarb\u012bba: no zin\u0101tnes l\u012bdz regul\u0113juma priek\u0161likumiem.\" width=\"1536\" height=\"1024\" loading=\"lazy\"><figcaption>Konceptu\u0101la ilustr\u0101cija. Priek\u0161likumi iesniegti 16.11.2026.<\/figcaption><\/figure>\n<p>2026. gada 16. novembr\u012b SIA \u201cCilmes \u0161\u016bnu tehnolo\u0123ijas\u201d TAP port\u0101l\u0101 iesniedza atzinumu par projektu 26-TA-2066 \u201cCilv\u0113kiem paredz\u0113to z\u0101\u013cu kl\u012bnisko p\u0113t\u012bjumu noteikumi\u201d. Ofici\u0101laj\u0101 dokument\u0101 Uldis B\u0113rzi\u0146\u0161 nor\u0101d\u012bts k\u0101 septi\u0146u iebildumu un viena priek\u0161likuma autors.<\/p>\n<p>Sadarb\u012bbas m\u0113r\u0137is ir mazin\u0101t nov\u0113r\u0161amu administrat\u012bvo un izmaksu slogu, saglab\u0101jot pacientu aizsardz\u012bbu, z\u0101\u013cu kvalit\u0101ti un datu ticam\u012bbu. Priek\u0161likumi skar inform\u0101cijas atk\u0101rtotas iesnieg\u0161anas nov\u0113r\u0161anu, p\u0113t\u012bjuma un standarta apr\u016bpes izmaksu nodal\u012b\u0161anu, apdro\u0161in\u0101\u0161anu, MVU atbalstu un skaidru ATMP kl\u012bnisko p\u0101rbau\u017eu, reto slim\u012bbu z\u0101\u013cu statusa un slimn\u012bcas iz\u0146\u0113muma no\u0161\u0137\u012brumu.<\/p>\n<div class=\"dp-timeline\">\n<div class=\"dp-card\"><span class=\"dp-num\">13.11.2026<\/span><\/p>\n<h3>Uz\u0146\u0113muma atzinums<\/h3>\n<p>Sagatavots Word dokuments par 26-TA-2066.<\/p>\n<\/div>\n<div class=\"dp-card\"><span class=\"dp-num\">16.11.2026<\/span><\/p>\n<h3>Ulda B\u0113rzi\u0146a iesniegums<\/h3>\n<p>TAP public\u0113ti 7 iebildumi un 1 priek\u0161likums.<\/p>\n<\/div>\n<div class=\"dp-card\"><span class=\"dp-num\">T\u0101l\u0101k<\/span><\/p>\n<h3>Priek\u0161likumu izv\u0113rt\u0113\u0161ana<\/h3>\n<p>L\u0113mumi par priek\u0161likumiem ir atbild\u012bgo iest\u0101\u017eu kompetenc\u0113.<\/p>\n<\/div>\n<\/div>\n<div class=\"dp-status\">\n<p>TAP atzinums iesniegts 2026. gada 16. novembr\u012b. Statuss \u201cNesaska\u0146ots\u201d ir uz\u0146\u0113muma saska\u0146o\u0161anas rezult\u0101ts par projektu. Tas neapliecina, ka ministrija atzinumu noraid\u012bjusi vai priek\u0161likumi jau pie\u0146emti. \u0160eit dokument\u0113ta l\u012bdzdal\u012bba regul\u0113juma izstr\u0101d\u0113; t\u0101 nav \u0101rst\u0113\u0161anas at\u013cauja vai kl\u012bnisk\u0101s efektivit\u0101tes apliecin\u0101jums.<\/p>\n<\/div>\n<section>\n<h2>Dokumenti un avoti<\/h2>\n<p>Apstiprin\u0101tiem investoriem pieejams pilns 13. novembra Word ori\u0123in\u0101lteksts bez labojumiem un visi asto\u0146i TAP ieraksti. Vietnes materi\u0101ls pieejams latvie\u0161u un ang\u013cu valod\u0101; ori\u0123in\u0101lie avoti saglab\u0101ti latviski.<\/p>\n<p><a class=\"dp-button\" href=\"\/lv\/investor-portal\/clinical-trial-proposals-26-ta-2066\/\">Atv\u0113rt investoru materi\u0101lus<\/a><a href=\"\/lv\/for-investors\/\">Pieteikt piek\u013cuvi<\/a><\/p>\n<ul>\n<li><a href=\"https:\/\/tapportals.mk.gov.lv\/legal_acts\/54ae0731-5202-4615-8ec5-24617d4477c1\">TAP projekta kart\u012bte<\/a><\/li>\n<li><a href=\"https:\/\/tapportals.mk.gov.lv\/reviews\/resolutions\/6ce9f8a8-9e47-4c55-8c6a-c4c901cf8738\">Uz\u0146\u0113muma atzinums TAP port\u0101l\u0101<\/a><\/li>\n<li><a href=\"https:\/\/tapportals.mk.gov.lv\/attachments\/legal_acts\/reviews\/additional_documents\/4a71df27-a87a-4d29-be10-ef2c6f6cd055\/download\">Ofici\u0101lais TAP atzinums (Word; ietver autorus)<\/a><\/li>\n<\/ul>\n<p><a href=\"\/lv\/insights\/\">Atgriezties Insights<\/a><\/p>\n<\/section>\n<\/article>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":447,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-with-title","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-787","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/pages\/787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/comments?post=787"}],"version-history":[{"count":1,"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/pages\/787\/revisions"}],"predecessor-version":[{"id":788,"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/pages\/787\/revisions\/788"}],"up":[{"embeddable":true,"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/pages\/447"}],"wp:attachment":[{"href":"https:\/\/depcell.com\/lv\/wp-json\/wp\/v2\/media?parent=787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}